These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27811370)
41. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas. Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164 [TBL] [Abstract][Full Text] [Related]
42. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma. Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988 [TBL] [Abstract][Full Text] [Related]
43. Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings. Narang AK; Chaichana KL; Weingart JD; Redmond KJ; Lim M; Olivi A; Quinones-Hinojosa A; Kleinberg LR World Neurosurg; 2017 Mar; 99():751-757. PubMed ID: 27108796 [TBL] [Abstract][Full Text] [Related]
44. TERT rs2853676 polymorphisms correlate with glioma prognosis in Chinese population. He X; Wei Y; Chen Z; Zhu X; Ma L; Zhang N; Zhang Y; Kang L; Yuan D; Zhang Z; Jin T Oncotarget; 2016 Nov; 7(45):73781-73791. PubMed ID: 27655710 [TBL] [Abstract][Full Text] [Related]
45. Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis. Zhang M; Zhao Y; Zhao J; Huang T; Wu Y BMC Neurol; 2019 Nov; 19(1):296. PubMed ID: 31759389 [TBL] [Abstract][Full Text] [Related]
46. PRKDC regulates chemosensitivity and is a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients. Sun G; Yang L; Dong C; Ma B; Shan M; Ma B Oncol Rep; 2017 Jun; 37(6):3536-3542. PubMed ID: 28498431 [TBL] [Abstract][Full Text] [Related]
47. Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma. Tian X; Zhang L; Sun L; Xue Y; Xie S J Int Med Res; 2014 Jun; 42(3):651-8. PubMed ID: 24743871 [TBL] [Abstract][Full Text] [Related]
48. CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection. Tang W; Wang X; Chen Y; Zhang J; Chen Y; Lin Z Pathol Biol (Paris); 2015 Sep; 63(4-5):190-8. PubMed ID: 26277915 [TBL] [Abstract][Full Text] [Related]
49. HIF-1α genetic variants and protein expression confer the susceptibility and prognosis of gliomas. Yi L; Hou X; Zhou J; Xu L; Ouyang Q; Liang H; Zheng Z; Chen H; Xu M Neuromolecular Med; 2014 Sep; 16(3):578-86. PubMed ID: 24929654 [TBL] [Abstract][Full Text] [Related]
50. Diagnostic and prognostic value of serum vitronectin levels in human glioma. Chen MH; Lu C; Sun J; Chen XD; Dai JX; Cai JY; Chen XL J Neurol Sci; 2016 Dec; 371():54-59. PubMed ID: 27871448 [TBL] [Abstract][Full Text] [Related]
51. Identification of microRNA-205 as a potential prognostic indicator for human glioma. Hou SX; Ding BJ; Li HZ; Wang L; Xia F; Du F; Liu LJ; Liu YH; Liu XD; Jia JF; Li L; Wu ZL; Zhao G; Zhang ZG; Deng YC J Clin Neurosci; 2013 Jul; 20(7):933-7. PubMed ID: 23683741 [TBL] [Abstract][Full Text] [Related]
52. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients. Chen W; Yu Q; Chen B; Lu X; Li Q Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144 [TBL] [Abstract][Full Text] [Related]
53. A network model of a cooperative genetic landscape in brain tumors. Bredel M; Scholtens DM; Harsh GR; Bredel C; Chandler JP; Renfrow JJ; Yadav AK; Vogel H; Scheck AC; Tibshirani R; Sikic BI JAMA; 2009 Jul; 302(3):261-75. PubMed ID: 19602686 [TBL] [Abstract][Full Text] [Related]
55. The relationship between polymorphisms of XRCC5 genes with astrocytoma prognosis in the Han Chinese population. He X; Zhu X; Li L; Zhang J; Wu R; Zhang Y; Kang L; Yuan D; Jin T Oncotarget; 2016 Dec; 7(51):85283-85290. PubMed ID: 27852033 [TBL] [Abstract][Full Text] [Related]
56. Long-term outcome of centrally located low-grade glioma in children. Terashima K; Chow K; Jones J; Ahern C; Jo E; Ellezam B; Paulino AC; Okcu MF; Su J; Adesina A; Mahajan A; Dauser R; Whitehead W; Lau C; Chintagumpala M Cancer; 2013 Jul; 119(14):2630-8. PubMed ID: 23625612 [TBL] [Abstract][Full Text] [Related]
57. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma. He S; Deng J; Li G; Wang B; Cao Y; Tu Y Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575 [TBL] [Abstract][Full Text] [Related]
58. Survival and low-grade glioma: the emergence of genetic information. Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286 [TBL] [Abstract][Full Text] [Related]
59. Characteristics of childhood glial tumors, management approaches and life expectancy of the patients. Arslan A; Guney Y; Cihan YB; Cetindag MF J BUON; 2014; 19(3):724-32. PubMed ID: 25261659 [TBL] [Abstract][Full Text] [Related]
60. Perfusion MRI derived indices of microvascular shunting and flow control correlate with tumor grade and outcome in patients with cerebral glioma. Tietze A; Mouridsen K; Lassen-Ramshad Y; Østergaard L PLoS One; 2015; 10(4):e0123044. PubMed ID: 25875182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]